Product Images Milrinone Lactate In Dextrose

Milrinone Lactate is a sterile and non-pyrogenic solution that contains 20 mg of Milrinone Lactate in 5% Dextrose Injection per 100 ml bag. It is intended for intravenous use only and must be administered as directed by a physician. This solution must not be used in series connections and should not be administered simultaneously with blood. The solution should be clear, colorless to pale yellow before using it. It is manufactured by Hospira and distributed by Gland Pharma Limited, India. The bag must be checked for minute leaks and should be stored at 20°C to 25°C (68°F to 77°F) to avoid freezing. The text mentions that more information is provided in the package insert.*

Milrinone Lactate 100ml is a solution for intravenous injection containing 20mg of milrinone lactate per 100ml of 5% dextrose injection. The product has a GTIN code of 40R045100 and a LOT number of ABc123 with an expiry date denoted by MMYYYY.*

Milrinone Lactate is presented in a 100 ml dose for intravenous use. It is a sterile, nonpyrogenic, and preservative-free solution of milrinone lactate, lactic acid, and dextrose in water for injection. Each mL contains 0.2 mg of milrinone lactate, 0.282 mg of lactic acid, and 54.3 mg of dextrose hydrous USP. The recommended dosage should be checked from the package insert. The solution should be clear, colorless to pale yellow, and should not be used if it contains leaks. It is stored in controlled room temperature but may be briefly exposed up to 40°C. It is distributed by Hospra, Inc, Lake Fores, IL, USA, and manufactured by Giant Pharma Limited.*

Milrinone Lactate in 5% Dextrose Injection is a sterile, nonpyrogenic solution for intravenous administration. Each 200 mL single dose contains 40 mg of milrinone lactate, equivalent to 0.2 mg/mL, in 5% dextrose injection. The solution is clear colorless to pale yellow, and no preservative is added. It is manufactured by Gland Pharma Limited in Hyderabad, India, and distributed by Hospira, Inc. in Lake Forest, IL, USA. The usual dosage is intravenously as directed by a physician. However, it must not be used in series connections and should not be administered simultaneously with blood. Check for leaks and discard if any are found. Store at 20°C to 25°C (68°F to 77°F) to ensure product quality.*

This is a product description for a 10% Milrinone Lactate in 5% Dextrose Injection solution contained in 200 mL Single Dose Containers. The solution is for intravenous use only and is manufactured by Grand Pharma in India and distributed by Hospira in the United States. The package contains 10 single-dose containers, each with 40 mg of Milrinone Lactate in a 200 mL solution of 5% Dextrose. The dosage and administration information are provided in the package insert. The product should be stored at controlled room temperature and should not be used if there are any leaks or discolorations. The lot number, expiration date, and serial number are printed on each container, and variable data and serialization are printed online.*

Milrinone 200 mL Pouch Label for intravenous use is used in short-term treatment to increase the heart's pumping action. This product contains Milrinone Lactate in 5% Dextrose Injection, which is used in a single dose. Each mL contains mirinone lactate equivalent to 0.2 mg. The usual dosage must be followed as per package insert. The medication comes in a pouch label, which has an overwrap that acts as a moisture barrier. The product must not be used in series connections nor with blood simultaneously. The product is non-pyrogenic and without any preservative. The solution must be clear, colorless to pale yellow. The storage temperature required is between 20°C to 25°C. The product is not made with natural rubber latex. The Manufacturer's protocol must be followed to use the product effectively.*

Not available. This is a chemical formula and requires additional context or information to generate a description.*